EMA — authorised 19 June 2015
- Marketing authorisation holder: Bristol-Myers Squibb
- Status: approved
🇪🇺 Opdivo in European Union
EMA authorised Opdivo on 19 June 2015
Marketing authorisation
Opdivo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Opdivo approved in European Union?
Yes. EMA authorised it on 19 June 2015.
Who is the marketing authorisation holder for Opdivo in European Union?
Bristol-Myers Squibb holds the EU marketing authorisation.